Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Combined use of starter cultures and preservatives to control production of biogenic amines and improve sensorial profile in low-acid salami.

Coloretti F, Chiavari C, Armaforte E, Carri S, Castagnetti GB.

J Agric Food Chem. 2008 Dec 10;56(23):11238-44. doi: 10.1021/jf802002z.

PMID:
18986149
3.

Immediate radical prostatectomy in patients with atypical small acinar proliferation. Over treatment?

Brausi M, Castagnetti G, Dotti A, De Luca G, Olmi R, Cesinaro AM.

J Urol. 2004 Sep;172(3):906-8; discussion 908-9.

PMID:
15310995
4.

Apoptosis in prostate carcinoma before and after neoadjuvant therapy with LH-RH analog.

Bencini S, Migaldi M, Castagnetti G, Pincelli C, Ferrari P, De Gaetani C, Trentini GP.

Ann N Y Acad Sci. 2003 Dec;1010:789-92.

PMID:
15033829
5.

Expression of p53 and bcl-2 in clinically localized prostate cancer before and after neo-adjuvant hormonal therapy.

Cesinaro AM, Migaldi M, Ferrari G, Castagnetti G, Dotti A, De Gaetani C, Ferrari P, Trentini GP.

Oncol Res. 2000;12(1):43-9.

PMID:
11061345
6.

Combination treatment versus LHRH alone in advanced prostatic cancer.

Ferrari P, Castagnetti G, Ferrari G, Baisi B, Dotti A.

Urol Int. 1996;56 Suppl 1:13-7.

PMID:
8776812
7.

Combination treatment in M1 prostate cancer.

Ferrari P, Castagnetti G, Ferrari G, Pollastri CA, Tavoni F, Dotti A.

Cancer. 1993 Dec 15;72(12 Suppl):3880-5.

PMID:
8252509
8.

[Ultrasound and color Doppler in the diagnosis of vasculogenic impotence].

Ferrari G, Talia B, Castagnetti G, Ferrari P.

Arch Ital Urol Nefrol Androl. 1992 Jun;64 Suppl 2:97-101. Italian.

PMID:
1411606
9.

Chemoimmunotherapy for prophylaxis of recurrence in superficial bladder cancer: interferon-alpha 2b versus interferon-alpha 2b with epirubicin.

Ferrari P, Castagnetti G, Pollastri CA, Ferrari G, Tavoni F, Grassi D.

Anticancer Drugs. 1992 May;3 Suppl 1:25-7.

PMID:
1611113
10.

Methotrexate, vinblastine, epidoxorubicin and cisplatin (M-VEC) in patients with locally advanced transitional bladder cancer.

Frassoldati A, Federico M, Barbieri F, Brausi M, Pollastri C, Berri G, Castagnetti G, Palladini PP, Silingardi V.

Med Oncol Tumor Pharmacother. 1991;8(2):99-103.

PMID:
1749307
11.

Neoplastic thrombosis in the renal cancer.

Ferrari P, Grassi D, Castagnetti G, Pollastri CA, Ferrari G.

Eur Urol. 1990;17(1):27-9.

PMID:
2318235
12.

[Proximal selective vagotomy and the lower esophageal sphincter. Experimental research].

Monni S, Roddi R, Melita V, Amorotti C, Sampietro L, Collu V, Castagnetti G.

Minerva Dietol Gastroenterol. 1986 Apr-Jun;32(2):173-6. Italian. No abstract available.

PMID:
3736965
13.

[Pathology of the urinary excretory tract and renal damage in female genital prolapse].

Andriani A, Castagnetti GL.

Minerva Ginecol. 1972 Mar 15;24(4):202-11. Italian. No abstract available.

PMID:
4671807
14.

[Relation between sulfobromophthalein Au-198 clearance and scintigraphic aspects in hepatopathies].

Maduli S, Castagnetti GL.

G Clin Med. 1970 Mar;51(3):180-256. Italian. No abstract available.

PMID:
5477744
15.

[Scintiscanning of the skeleton with Sr-85. (Clinico-diagnostic use)].

Malaspina A, Cardinali P, Castagnetti GL.

Radiobiol Radioter Fis Med. 1968 Sep-Oct;23(5):331-50. Italian. No abstract available.

PMID:
5717853
16.

[Studies of radioactivity in puerperal milk exposed to radionephrographic examination with hippuran-I-131].

Andriani A, Castagnetti GL.

Minerva Ginecol. 1968 Jan 31;20(2):118-21. Italian. No abstract available.

PMID:
5754325
17.

[Radionephrographic study of renal function in the firxt days of the puerperium].

Andriani A, Castagnetti GL.

Minerva Ginecol. 1968 Jan 15;20(1):30-6. Italian. No abstract available.

PMID:
5736959
18.

[Renal function after radical gynecological surgery. Radionephrographic, urographic and biochemical study].

Andriani A, Sorrentino R, Castagnetti GL.

Minerva Ginecol. 1967 Sep 15;19(17):870-8. Italian. No abstract available.

PMID:
5615832

Supplemental Content

Loading ...
Support Center